1 – 19 of 19
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019 : a registry-based cohort study
(
- Contribution to journal › Article
-
Mark
The remote exercise SWEDEHEART study–Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT)
(
- Contribution to journal › Article
-
Mark
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
(
- Contribution to journal › Article
-
Mark
Prognostic Value of Early Sustained Ventricular Arrhythmias in ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention : A Substudy of VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
- 2022
-
Mark
Participation in exercise-based cardiac rehabilitation is related to reduced total mortality in both men and women : Results from the SWEDEHEART registry
(
- Contribution to journal › Article
- 2021
-
Mark
The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)
(
- Contribution to journal › Article
- 2019
-
Mark
Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden : a report from the Swedish Coronary and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
- 2018
-
Mark
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction : A report from the Swedish Coronary Angiography and Angioplasty Registry
(
- Contribution to journal › Article
-
Mark
Culprit and nonculprit recurrent ischemic events in patients with myocardial infarction : Data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies)
(
- Contribution to journal › Article
- 2017
-
Mark
The Reply Refers ToTomoyuki Kawada Prognosis in Patients with Different Types of Myocardial Infarction and Presence of Obstructive Coronary Artery Disease
(
- Contribution to journal › Letter
-
Mark
Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
- 2016
-
Mark
Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction.
(
- Contribution to journal › Article
- 2015
-
Mark
Type 2 myocardial infarction in clinical practice.
(
- Contribution to journal › Article
-
Mark
Replik till Åke Thörn och Bengt Järhult: - Seriös diskussion om kvalitetsregister välkomnas
(
- Contribution to journal › Letter
- 2014
-
Mark
Target-Attainment Rates of Low-Density Lipoprotein Cholesterol Using Lipid-Lowering Drugs One Year After Acute Myocardial Infarction in Sweden
(
- Contribution to journal › Article
-
Mark
Stent Thrombosis in New-Generation Drug-Eluting Stents in Patients With STEMI Undergoing Primary PCI: A Report From SCAAR.
(
- Contribution to journal › Article
-
Mark
SWEDEHEART Annual Report 2012
(
- Contribution to journal › Article
-
Mark
Swedeheart : Annual Report 2013
2014)(
- Book/Report › Report
- 2013
-
Mark
The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART).
(
- Contribution to journal › Article